UNSPSC 51192432: Calcium glycerophosphate/calcium levulinate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class TN420. This VA Drug Class (TN420) classifies this compound as belonging to the group CALCIUM.

UNSPSC 51192432 Calcium glycerophosphate/calcium levulinate is a Commodity code covering specialized pharmaceutical and nutritional supplement ingredients used in medical formulations and fortified products. State and local government procurement under this code centers on bulk chemical supply for public health programs, hospital systems, and institutional nutrition initiatives where calcium supplementation or pharmaceutical formulation requires these specific compounds. Issuing bodies include state health departments, county public health agencies, municipal hospital systems, and regional health authorities that source these ingredients for clinical compounding, intravenous therapy preparation, or fortified food and beverage programs serving vulnerable populations including pediatric patients, elderly populations in long-term care, and institutional feeding programs.

Recent state and local procurement activity under this code is minimal; the source provides no posted solicitations or contract opportunities. Without activity data from recent RFP, RFQ, IFB, or ITB notices, geographic concentration and representative opportunities cannot be characterized. Buyers pursuing this commodity should monitor state health department procurement channels and hospital cooperative purchasing vehicles for episodic demand, as institutional procurement of pharmaceutical-grade calcium compounds typically follows budget cycles or inventory replacement schedules rather than continuous competitive solicitation.